2 mL Multiple-Dose Fliptop Vial Rx onlyNDC 0409-3578-01Contains 25 of NDC 0409-3578-11 Tobramycin Injection, USP80 mg/2 mL (40 mg/mL) WARNING: CONTAINS SULFITESFor intramuscular or intravenous use.Must dilute for intravenous use. HospiraTOBRAMYCIN...
197 Comparison of tobramycin 80 mg (IV-preparation) and 300 mg solution inhaled twice daily for chronic P. aeruginosa infectiondoi:10.1016/S1569-1993(05)80175-4Elsevier BVJournal of Cystic Fibrosis
Continuous intravenous infusion of 6.6 mg/h and 30 mg/h produced steady-state concentrations of 1 and 3.5–4.5 mg/L, respectively. Higher concentrations (10–12 mg/L) have been obtained by bolus injection over about 3 min. Peak concentrations of around 50 mg/L have been reported in ...
Clindamycinis the 7(S)-chlorodeoxylincomycin derivative.Pirlimycinis the 4-cis-ethyl-l-pipecolic derivative of clindamycin. For oral use, apalmitatesalt of clindamycin hydrochlorine is available; for injection,clindamycin phosphateis available.33 ...
H2N NH2 Each mL contains Active: Tobramycin sulfate equivalent to 40 mg tobramycin; Preservative: phenol 5 mg; Inactives: 0.1 mg edetate disodium; sodium bisulfite 3.2 mg; sulfuric acid and/or sodium hydroxide may have been added to adjust the pH (3.0 to 6.5) and water for injection, q....
[4] Dosage: 7.5,15,30,120,441,969 mg/kg Administration: Subcutaneous injection (s.c.), Intravenous injection (i.v.) ,Intramuscular injection(i.m.) Result: The s.c. LD50 values in mice and rats were 441 and 969 mg/kg, respectively. Within 1 hour after treated, death with central ...
A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients. Can Respir J. 2008; 15 :259–62.Nikolaizik, W.H.; Vietzke, D.; Ratjen, F. A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg ...
[4] Dosage: 7.5,15,30,120,441,969 mg/kg Administration: Subcutaneous injection (s.c.), Intravenous injection (i.v.) ,Intramuscular injection(i.m.) Result: The s.c. LD50 values in mice and rats were 441 and 969 mg/kg, respectively. Within 1 hour after treated, death with central ...
Smilga et al. reported a case of MIRM in a 44-year-old woman who developed bilateral conjunctival injection with 360-degree ulcerations of the bulbar conjunctiva and eyelid margins after one month of cough and fever [47] (Fig. 3). She was diagnosed with MIRM and was treated with oralpr...
The active treatment was a solution of 150 mg tobramycin for inhalation by nebulization in a single dose of 3 ml medium (150 mg/3 ml), administered by the Easynose® mesh nebulizer. The solution was composed of tobramycin 150 mg, water for injection qs 3 ml, and NaCI. The isotonic sa...